Impact of 25-Hydroxyvitamin D Deficiency on Perioperative Parathyroid Hormone Kinetics and Results in Patients with Primary Hyperparathyroidism

Surgery

Volumn 142, Issue 6, 2007, Pages 1022-1026

  Untch, Brian R ^a   Barfield, Michael E ^a   Dar, Moahad ^a   Dixit, Darshana ^a   Leight Jr , George S ^a   Olson Jr , John A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; PARATHYROID HORMONE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID ADENOMA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN INCISION; SURGICAL PATIENT; TUMOR VOLUME; VITAMIN D DEFICIENCY;

ADENOMA; ADULT; AGED; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; CALCIUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, PRIMARY; KINETICS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 36548998763     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.09.026     Document Type: Article

References (24)

1. Bilezikian J.P., and Silverberg S.J. Clinical Practice. Asymptomatic primary hyperparathyroidism. N Engl J Med 350 (2004) 1746-1751
2. Proye C., Goropoulos A., Franz C., Carnaille B., Vix M., Quievreux J.L., et al. Usefulness and limits of quick intraoperative measurements of intact (1-84) parathyroid hormone in the surgical management of hyperparathyroidism: sequential measurements in patients with multiglandular disease. Surgery 110 (1991) 1035-1042
3. Chapuis Y., Icard P., Fulla Y., Nonnenmacher L., Bonnichon P., Louvel A., et al. Parathyroid adenomectomy under local anesthesia with intra-operative monitoring of UcAMP and/or 1-84 PTH. World J Surg 16 (1992) 570-575
4. Irvin G.L., Solorzano C.C., and Carneiro D.M. Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg 28 (2004) 1287-1292
5. Carty S.E., Roberts M.M., Virji M.A., Haywood L., and Yim J.H. Elevated serum parathormone level after "concise parathyroidectomy" for primary sporadic hyperparathyroidism. Surgery 132 (2002) 1086-1092
6. Yamashita H., Noguchi S., Moriyama T., Takamatsu Y., Sadanaga K., Uchino S., et al. Reelevation of parathyroid hormone level after parathyroidectomy in patients with primary hyperparathyroidism: importance of decreased renal parathyroid hormone sensitivity. Surgery 137 (2005) 419-425
7. Fukagawa M., Nakanishi S., Fujii H., Hamada Y., and Abe T. Regulation of parathyroid function in chronic kidney disease (CKD). Clin Exp Nephrol 10 (2006) 175-179
8. Korkor A.B. Reduced binding of 1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure. N Engl J Med 316 (1987) 1573-1577
9. Fukuda N., Tanaka H., Tominaga Y., Fukagawa M., Kurokawa K., and Seino Y. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92 (1993) 1436-1443
10. Carling T., Rastad J., Szabo E., Westin G., and Akerstrom G. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. J Clin Endocrinol Metab 85 (2000) 2000-2003
11. Rao D.S., Honasoge M., Divine G.W., Phillips E.R., Lee M.W., Ansari M.R., et al. Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 85 (2000) 1054-1058
12. Yano S., Sugimoto T., Tsukamoto T., Chihara K., Kobayashi A., Kitazawa S., et al. Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas. Eur J Endocrinol 148 (2003) 403-411
13. Naveh-Many T., Marx R., Keshet E., Pike J.W., and Silver J. Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo. J Clin Invest 85 (1990) 1968-1975
14. Fukagawa M., Kaname S., Igarashi T., Ogata E., and Kurokawa K. Regulation of parathyroid hormone synthesis in chronic renal failure in rats. Kidney Int 39 (1991) 874-881
15. Wang T.S., Ostrower S.T., and Heller K.S. Persistently elevated parathyroid hormone levels after parathyroid surgery. Surgery 138 (2005) 1130-1135
16. Ozbey N., Erbil Y., Ademoglu E., Ozarmagan S., Barbaros U., and Bozbora A. Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism. World J Surg 30 (2006) 321-326
17. Moosgaard B., Vestergaard P., Heickendorff L., Melsen F., Christiansen P., and Mosekilde L. Plasma 25-hydroxyvitamin D and not1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross sectional study. Eur J Endocrinol 155 (2006) 237-244
18. Johnson L.R., Doherty G., Lairmore T., Moley J.F., Brunt L.M., Koenig J., et al. Evaluation of the performance and clinical impact of a rapid intraoperative parathyroid hormone assay in conjunction with preoperative imaging and concise parathyroidectomy. Clin Chem 47 (2001) 919-925
19. Stalberg P., Sidhu S., Sywak M., Robinson B., Wilkinson M., and Delbridge L. Intraoperative parathyroid hormone measurement during minimally invasive parathyroidectomy: does it "value-add" to decision-making?. J Am Coll Surg 203 (2006) 1-6
20. Weber K.J., Misra S., Lee J.K., Wilhelm S.W., DeCresce R., and Prinz R.A. Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Surgery 136 (2004) 1154-1159
21. Moe S.M., and Drueke T.B. Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product. Am J Nephrol 23 (2003) 369-379
22. Goodman W.G. The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease. Semin Dial 17 (2004) 209-216
23. Prince R.L., Dick I.M., Lemmon J., and Randell D. The pathogenesis of age-related osteoporotic fracture: effects of dietary calcium deprivation. J Clin Endocrinol Metab 82 (1997) 260-264
24. Selby P.L., Davies M., Adams J.E., and Mawer E.B. Bone loss in celiac disease is related to secondary hyperparathyroidism. J Bone Miner Res 14 (1999) 652-657